The Gastrointestinal Safety and Effect on Disease Activity of Etoricoxib, a Selective Cox-2 Inhibitor in Inflammatory Bowel Diseases

O'Neill GP, 1993, FEBS Lett, 330, 156, 10.1016/0014-5793(93)80263-T

Flemstrom G, 1980, Am J Physiol, 239, G198

Miller TA, 1983, Am J Physiol, 245, G601

Maier JAM, 1990, J Biol Chem, 265, 1085

Lee SH, 1992, J Biol Chem, 267, 25934, 10.1016/S0021-9258(18)35698-9

O'Banion MK, 1992, Proc Natl Acad Sci U S A, 89, 4888, 10.1073/pnas.89.11.4888

10.1002/ddr.430250402

Cohn SM, 1997, J Clin Invest, 99, 1367, 10.1172/JCI119296

Eckman L, 1997, J Clin Invest, 100, 296, 10.1172/JCI119535

Jung HC, 1995, J Clin Invest, 95, 55, 10.1172/JCI117676

Evans JM, 1997, Gut, 40, 619, 10.1136/gut.40.5.619

10.1111/j.1572-0241.2000.02262.x

Kaufmann HJ, 1987, Ann Intern Med, 107, 513, 10.7326/0003-4819-107-4-513

Rampton DS, 1981, Postgrad Med J, 57, 297, 10.1136/pgmj.57.667.297

10.1111/j.1572-0241.2000.02263.x

Dominitz JA, 2000, Gastroenterology, 118, A3024, 10.1016/S0016-5085(00)84462-5

10.1111/j.1572-0241.2001.03671.x

Munkholm P, 1995, Scand J Gastroenterol, 30, 699, 10.3109/00365529509096316

Sanborn WJ, 2004, Am J Gastroenterol., 99, S257, 10.14309/00000434-200410001-00790

10.1111/j.1572-0241.2002.05608.x

10.1016/S0016-5085(98)70196-9

Hendel J, 1997, Am J Gastroenterol, 92, 1170

Su LK, 1992, Science, 256, 668, 10.1126/science.1350108

10.1053/gast.1997.v112.pm9024292

Shigeta J, 1998, J Pharmacol Exp Ther, 286, 1383

Reuter BK, 1996, J Clin Invest, 98, 2076, 10.1172/JCI119013

Karmeli F, 2000, Eur J Gasteroenterol Hepatol, 12, 223, 10.1097/00042737-200012020-00015

10.1056/NEJMoa021907

Laine L, 2004, Rev Gastroenterol Disord, 4, S33